Matches in Wikidata for { <http://www.wikidata.org/entity/Q82774949> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q82774949 description "article scientifique publié en 2011" @default.
- Q82774949 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q82774949 description "im Dezember 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82774949 description "scientific article published on 01 December 2011" @default.
- Q82774949 description "wetenschappelijk artikel" @default.
- Q82774949 description "наукова стаття, опублікована в грудні 2011" @default.
- Q82774949 name "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 name "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 type Item @default.
- Q82774949 label "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 label "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 prefLabel "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 prefLabel "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 P1433 Q82774949-42904D6C-F9BE-4C1F-8682-ADF169640485 @default.
- Q82774949 P1476 Q82774949-78133649-074B-4973-AA76-BB8E6D34224C @default.
- Q82774949 P2093 Q82774949-02FF20E8-BC2F-4FFF-9A9B-C61A83D72446 @default.
- Q82774949 P2093 Q82774949-0386AD61-1D6D-4BCA-ADF3-7B120AC66C8E @default.
- Q82774949 P2093 Q82774949-2C7A751F-D7CC-4CDA-89E5-7FDBA8740DF3 @default.
- Q82774949 P2093 Q82774949-36DBF738-C401-4B7B-8E4E-94A2ED5C330E @default.
- Q82774949 P2093 Q82774949-3E812FEF-002B-423A-8602-29D002EB2199 @default.
- Q82774949 P2093 Q82774949-5CA35377-AA0E-4424-8E89-63F3EA0BA2F1 @default.
- Q82774949 P2093 Q82774949-5FE48EFE-C760-4626-BEC8-6BE9D76516B9 @default.
- Q82774949 P2093 Q82774949-76245EAB-AABA-4459-9FB6-3F0BE051F7EA @default.
- Q82774949 P2093 Q82774949-9DC75CDB-8E45-433F-AD62-89335BB140AB @default.
- Q82774949 P2093 Q82774949-C38D401A-07C2-46F6-BB13-11C409967CD6 @default.
- Q82774949 P2093 Q82774949-C739B4DB-FAB2-4B52-B1F0-222F3C7BCAE1 @default.
- Q82774949 P2093 Q82774949-FBC9BC86-9000-4002-BCB8-E70E7A86F8AA @default.
- Q82774949 P304 Q82774949-C96BB938-9A43-4016-9CE4-9975BBF8CB65 @default.
- Q82774949 P31 Q82774949-BA3FAF07-AA3D-4E1B-82EE-753DB5422C09 @default.
- Q82774949 P356 Q82774949-FFA1406A-373C-431D-B5EB-FCB80ABB88E5 @default.
- Q82774949 P433 Q82774949-599AF085-90E7-4B2D-AF11-6E06DD34C5A6 @default.
- Q82774949 P478 Q82774949-0C04111B-7753-45A3-B922-A85BBE656516 @default.
- Q82774949 P50 Q82774949-AC2CEAFB-1EBC-484E-8BC6-746589DABA4D @default.
- Q82774949 P577 Q82774949-09346017-D242-4757-B0A9-FC7605ABA836 @default.
- Q82774949 P698 Q82774949-6229CEF7-4978-4919-ADF0-8EA631B60DA8 @default.
- Q82774949 P356 CIRCGENETICS.111.960252 @default.
- Q82774949 P698 22135385 @default.
- Q82774949 P1433 Q15816430 @default.
- Q82774949 P1476 "The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies" @default.
- Q82774949 P2093 "Aurobindo Chatterjee" @default.
- Q82774949 P2093 "Benoit J Arsenault" @default.
- Q82774949 P2093 "Craig L Hyde" @default.
- Q82774949 P2093 "David A DeMicco" @default.
- Q82774949 P2093 "David D Waters" @default.
- Q82774949 P2093 "G Kees Hovingh" @default.
- Q82774949 P2093 "John C LaRosa" @default.
- Q82774949 P2093 "Philip Barter" @default.
- Q82774949 P2093 "Prakash Deedwania" @default.
- Q82774949 P2093 "S Matthijs Boekholdt" @default.
- Q82774949 P2093 "TNT and IDEAL Investigators" @default.
- Q82774949 P2093 "Terje R Pedersen" @default.
- Q82774949 P304 "51-57" @default.
- Q82774949 P31 Q13442814 @default.
- Q82774949 P356 "10.1161/CIRCGENETICS.111.960252" @default.
- Q82774949 P433 "1" @default.
- Q82774949 P478 "5" @default.
- Q82774949 P50 Q110410211 @default.
- Q82774949 P577 "2011-12-01T00:00:00Z" @default.
- Q82774949 P698 "22135385" @default.